Ready for a sneak peek at what you’ll find at ECCMID 2019? Or are you looking to stay on top of the latest news even if you aren’t going? Either way, you’re in the right place! Read on to hear a bit about what bioMérieux has for you at Stand 1.3.


bioMérieux and you, partners in Antimicrobial Stewardship

Future generations need us to sustain antibiotic efficacy and curb resistance – and appropriate use of antibiotics is key. Diagnostics play an essential role, providing actionable information to support decisions for antibiotic initiation, optimization and discontinuation.


bioMérieux is committed to working with labs and healthcare professionals to raise awareness and find solutions for the global healthcare threat of antimicrobial resistance – and we’re dedicating our presence at ECCMID to this cause. Together with you, we are for advancing antimicrobial stewardship (AMS).


If you work in healthcare or diagnostics then bookmark this Symposium! You’re sure to find insights for your lab as four leading experts discuss innovations and strategies to boost the lab’s impact on AMS

bioMérieux Integrated Symposium overview

The Vital Role of Diagnostics in Antimicrobial Stewardship

Integrated Symposium • Amsterdam • Sunday April 14, 16:00-18:00 • Hall G

The respective role of key hospital stakeholders in AMS

Dr. Esmita Charani, PhD, MPharm, MSc, Department of Infectious Diseases, Imperial College • UK


Using syndromic testing to challenge the paradigm of antibiotic use in patients with severe pneumonia

Dr. Pierre-François Laterre, MD, Head of the medical-surgical ICU, Saint-Luc, University Hospital • Belgium


Shortening the diagnostic turn-around time to optimize antibiotic therapy

Prof. Alex van Belkum, PhD, Scientific Director of Microbiology Research, bioMérieux • France


Impact of an effective clinical decision software on AMS

Prof. Louis Valiquette, MD, MSc, Department of Microbiology and Infectious Diseases, Université de Sherbrooke • Canada


ESCMID APPOINTED-CHAIR: Prof. Inge C. Gyssens • Radboud University Medical Center • Netherlands

BIOMÉRIEUX CHAIR: Prof. Christine Ginocchio • bioMérieux • USA

Featured solutions for AMS

You can count on bioMérieux’s comprehensive range of solutions to help advance AMS… and ECCMID is the best place to discover our latest innovations!

VITEK® 2 OPUS AST cards

One-card efficiency. More actionable information.


What if you could rapidly unlock more actionable antibiotic susceptibility testing (AST) information with no extra workflow steps? With VITEK® 2 OPUS AST cards – test up to 60% more antibiotics per card. Efficiently reduce the need for subsequent testing and report a refined set of results more easily.

PhenoMATRIX™ empowered by bioMérieux

Embedded interpretation intelligence for WASPLab®


WASPLab®’s new PhenoMATRIX™ expert module leverages artificial intelligence and embedded algorithms for rules-based sorting and plate interpretation. Focus your expertise on critical positive plates – with almost instant sorting, you may never need to touch a negative plate again!

BIOFIRE® FILMARRAY® Pneumonia Panel Plus

Don’t let pneumonia bugs sneak by undetected!


The BIOFIRE® FILMARRAY® Pneumonia Panel Plus is the first panel for 34 targets that cause pneumonia & LRTI. Simultaneous testing on the FILMARRAY® multiplex PCR means just two minutes of hands-on time and a turnaround time of about 1 hour. The FILMARRAY® range of panels is the largest syndromic testing menu commercially available.

Want to know more about these or any other bioMérieux solutions for antimicrobial stewardship?

Drop into stand 1.3 at ECCMID 2019 or contact us!

bioMérieux is committed to raising awareness on the prudent use of antibiotics and the global healthcare threat of antibiotic resistance. One of the ways we support antibiotic awareness is through the Global Point Prevalence Survey (Global-PPS)* initiative.


This annual survey coordinates surveillance of antimicrobial consumption and resistance rates in hospitals worldwide. It is now the largest antibiotic utilization surveillance system in the world – more than 800 hospitals in over 80 countries and growing.


Enroll your hospital and get access to worldwide data on antibiotic use, and see how your hospital compares with hundreds of others both nationally and internally. 


Optimizing Antibiotic Use - GPPS

Drop into our GPPS corner at ECCMID stand 1.3 to find out more

OR

*Project managed by the University of Antwerp (Belgium) and funded by bioMérieux.

bioMérieux and you, partners in Antimicrobial Stewardship!


The fight against Antibiotic Resistance keeps going after ECCMID!

Copyright bioMérieux 2019

Follow us: